JP2010530001A5 - - Google Patents

Download PDF

Info

Publication number
JP2010530001A5
JP2010530001A5 JP2010512395A JP2010512395A JP2010530001A5 JP 2010530001 A5 JP2010530001 A5 JP 2010530001A5 JP 2010512395 A JP2010512395 A JP 2010512395A JP 2010512395 A JP2010512395 A JP 2010512395A JP 2010530001 A5 JP2010530001 A5 JP 2010530001A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
sulfide
blood flow
nitric oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010512395A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010530001A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/066973 external-priority patent/WO2008157393A1/en
Publication of JP2010530001A publication Critical patent/JP2010530001A/ja
Publication of JP2010530001A5 publication Critical patent/JP2010530001A5/ja
Pending legal-status Critical Current

Links

JP2010512395A 2007-06-15 2008-06-13 硫化物単独または一酸化窒素との組み合わせを含む組成物およびその使用 Pending JP2010530001A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94444407P 2007-06-15 2007-06-15
PCT/US2008/066973 WO2008157393A1 (en) 2007-06-15 2008-06-13 Compositions comprising sulfide alone or in combination with nitric oxide and their use to

Publications (2)

Publication Number Publication Date
JP2010530001A JP2010530001A (ja) 2010-09-02
JP2010530001A5 true JP2010530001A5 (enExample) 2011-07-28

Family

ID=39670390

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010512395A Pending JP2010530001A (ja) 2007-06-15 2008-06-13 硫化物単独または一酸化窒素との組み合わせを含む組成物およびその使用

Country Status (4)

Country Link
US (3) US20100247680A1 (enExample)
EP (1) EP2155213A1 (enExample)
JP (1) JP2010530001A (enExample)
WO (1) WO2008157393A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2605631A1 (en) * 2005-04-20 2006-10-26 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms
EP1888510A4 (en) 2005-05-27 2013-01-16 Univ North Carolina NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
US7923037B2 (en) 2006-10-05 2011-04-12 Ikaria, Inc. Liquid chalcogenide compositions and methods of manufacturing and using the same
US20100183748A1 (en) * 2009-01-21 2010-07-22 Ikaria, Inc. Methods for Treating or Preventing Radiocontrast Agent Induced Kidney Injury
US8541396B2 (en) 2009-04-24 2013-09-24 National University Of Singapore Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) as a novel vasodilator agent
CA2763111C (en) 2009-05-27 2019-09-24 Ino Therapeutics Llc Devices and methods for engaging indexed valve and pressurized canister assembly with collar and for linear actuation by plunger assembly into fluid communication with device for regulating drug delivery
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
KR102304113B1 (ko) 2014-02-10 2021-09-24 프레드 헛친슨 켄서 리서치 센터 심장마비 및 허혈성 손상의 할로겐 치료
KR20240142604A (ko) * 2017-08-25 2024-09-30 말린크로트 파마슈티칼스 아일랜드 리미티드 기관 생존력을 개선시키는 방법
TWI650326B (zh) 2017-10-24 2019-02-11 國立交通大學 醫藥組合物、化合物的用途及合成方法
JP6618976B2 (ja) * 2017-11-14 2019-12-11 イノ セラピューティクス エルエルシー 指標付弁と襟部を有する加圧容器組立体を係合するため、かつ薬物送達を調整するための装置と流体連通したプランジャ組立体により直線的に作動させるための装置および方法
WO2020262055A1 (ja) * 2019-06-28 2020-12-30 住友精化株式会社 創傷治療用ガス組成物及び創傷治療装置
CN111228223B (zh) * 2020-03-06 2021-06-18 同济大学 一种促进伤口愈合的聚合物囊泡及其制备方法和应用
CN114099419B (zh) * 2021-11-19 2023-03-24 苏州大学 一种载硫氢化钠可注射纳米纤维化水凝胶及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0738766B1 (en) * 1995-04-20 2001-07-25 Clariant Finance (BVI) Limited Stable liquid suspensions of sulphur dyes and method for analyzing same
AU2002239748A1 (en) * 2000-12-15 2002-06-24 Galileo Laboratories, Inc. Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
CN1674942A (zh) * 2002-06-21 2005-09-28 联邦高等教育系统匹兹堡大学 氧化氮、血红素加氧酶－1和血红素降解产物的药学用途
US20050136125A1 (en) * 2003-10-22 2005-06-23 Roth Mark B. Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
CA2646674A1 (en) * 2006-04-20 2007-11-01 Fred Hutchinson Cancer Research Center Use of chalcogenides for treating shock and other adverse conditions
US20080187604A1 (en) * 2006-10-05 2008-08-07 Ikaria, Inc. Liquid chalcogenide compositions and methods of manufacturing and using the same
WO2008079993A2 (en) * 2006-12-22 2008-07-03 Ikaria, Inc. Combinations of nitric oxide and sulfide and methods of use and manufacture thereof

Similar Documents

Publication Publication Date Title
JP2010530001A5 (enExample)
JP2011520917A5 (enExample)
JP2014515028A5 (enExample)
JP2012505014A5 (enExample)
JP2021504423A5 (enExample)
MX2013001749A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
WO2011005538A3 (en) Methods and devices for remote ischemic preconditioning and near-continuous blood pressure monitoring
JP2007277274A5 (enExample)
JP2011057709A5 (enExample)
IL155524A (en) Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
JP2011503212A5 (enExample)
JP2010538020A5 (enExample)
JP2008545703A5 (enExample)
El-Tahan Preoperative ephedrine counters hypotension with propofol anesthesia during valve surgery: a dose dependent study
EA201070084A1 (ru) Новое применение известных фармакологически активных химических соединений
EA201071138A1 (ru) Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона
RU2004136583A (ru) Применение валсартана или его метаболита для ингибирования агрегации тромбоцитов
CN103340863A (zh) 烟酰胺在制备治疗糖尿病伤口愈合药物中的应用
Awsakulsutthi et al. Beraprost sodium for chronic diabetic foot ulcer: a randomized controlled trial in thammasat university hospital
HRP20200897T1 (hr) Parenteralna formulacija esmolola
RU2004121780A (ru) Способ лечения
CN202637268U (zh) 一种治疗心绞痛的双层药磁穴位敷贴
Oudemans-van Straaten Strategies to prevent contrast nephropathy
Ahmed et al. Anesthetic management of a patient with hypertrophic obstructive cardiomyopathy undergoing modified radical mastectomy
JP2007523111A5 (enExample)